Home
Medical Imaging
Molecular Imaging
PETNET radiopharmaceuticals
Advanced Accelerator Applications Molecular Imaging

Together Advanced Accelerator Applications molecular imaging and PETNET Solutions represent Siemens Healthineers PET radiopharmaceutical manufacturing and services, with 17 radiopharmacy manufacturing sites in six countries across Europe.

Advanced Accelerator Applications Molecular ImagingA Siemens Healthineers Company

As of December 2, 2024, Siemens Healthineers has completed the acquisition of Advanced Accelerator Applications Molecular Imaging operating in five countries within Europe. This acquisition complements Siemens Healthineers PETNET Solutions’ network of 47 radiopharmacies, primarily in the U.S., with an additional 13 manufacturing sites across France, Spain, Portugal, Italy and Germany, as well as product distribution into Switzerland.

As part of Siemens Healthineers, we are dedicated to developing, manufacturing and supplying radiopharmaceutical products for positron emission tomography (PET) imaging, such as FDG and choline. As a leading PET radiopharmaceutical manufacturing and service provider across the US and Europe, we offer scalable, efficient solutions to third-party drug developers as a preferred contract development and manufacturing organization (CDMO). We support third-party drug developers in bringing innovative tracers to market for personalized medicine and theranostics, while tailoring our services to meet regional needs and ensuring consistent, high-quality solutions globally.

PETNET Solutions and Advanced Accelerator Applications Molecular Imaging remain steadfast in our mutual dedication to exceptional quality and services, fostering innovation while prioritizing patient care.

Portrait of Barry Scott, CEO, PETNET Solutions, Inc. — Barry Scott, CEO of PETNET Solutions, a Siemens Healthineers company and Advanced Accelerator Applications Molecular Imaging, a Siemens Healthineers company

Welcome from Barry Scott

“We’re excited to share that we’ve completed the acquisition of Advanced Accelerator Applications Molecular Imaging from Novartis, strengthening our combined capabilities in PET imaging across Europe. As we integrate our two companies, it’s business as usual for you—there will be no disruptions to current operations or services. Our top priority is to continue providing reliable, high-quality radiopharmaceuticals with no impact to your experience.

We’re committed to bringing the best of both teams together, ensuring seamless day-to-day operations and staying focused on our mission: to deliver a comprehensive portfolio of PET radiopharmaceuticals that improve patient outcomes. With Advanced Accelerator Applications Molecular Imaging’s established manufacturing and distribution network, and our shared dedication to quality and innovation, this partnership enhances our ability to better serve you and support advancements in cancer care, neurology, cardiology, and theranostics. Together, we’re positioned to deliver even greater value to patients and customers, while advancing our vision for the future."

Barry Scott, CEO of PETNET Solutions

Who we are

Advanced Accelerator Applications Molecular Imaging, a Siemens Healthineers Company, develops, manufactures and delivers radiopharmaceutical products for positron emission tomography (PET) imaging.

Pharmacist working in France radiopharmacy

Delivering on time, every time

PET radiopharmaceuticals used in molecular imaging often contain isotopes with very short half-lives which means it decays quickly and loses effectiveness if not administered within a specific time frame. Many of today’s radiopharmaceuticals use F-18 which has a 110-minute half-life, making on time delivery crucial and essential to ensure the radiopharmaceutical reaches the patient for their scheduled PET scan appointment, on time, every time.

Advanced Accelerator Applications Molecular Imaging and Siemens Healthineers PETNET Solutions are now the largest PET radiopharmaceutical network globally, offering the most extensive PET radiopharmaceutical portfolio. As the CDMO of choice, we are deeply committed to advancing PET imaging by developing and manufacturing innovative tracers that support both diagnosis and theranostics - therapeutic diagnostics that enable more personalized and effective treatments. Together we can directly expand access to high-quality PET imaging, enhance diagnostic accuracy, and drive global advancements in patient outcomes and the effectiveness of precision medicine.

European sites

Together Advanced Accelerator Applications Molecular Imaging and PETNET Solutions represent Siemens Healthineers PET radiopharmaceutical manufacturing and services, with 16 radiopharmacy manufacturing sites in six countries across Europe.